Literature DB >> 15572684

Leukemogenesis caused by incapacitated GATA-1 function.

Ritsuko Shimizu1, Takashi Kuroha, Osamu Ohneda, Xiaoqing Pan, Kinuko Ohneda, Satoru Takahashi, Sjaak Philipsen, Masayuki Yamamoto.   

Abstract

GATA-1 is essential for the development of erythroid and megakaryocytic lineages. We found that GATA-1 gene knockdown female (GATA-1.05/X) mice frequently develop a hematopoietic disorder resembling myelodysplastic syndrome that is characterized by the accumulation of progenitors expressing low levels of GATA-1. In this study, we demonstrate that GATA-1.05/X mice suffer from two distinct types of acute leukemia, an early-onset c-Kit-positive nonlymphoid leukemia and a late-onset B-lymphocytic leukemia. Since GATA-1 is an X chromosome gene, two types of hematopoietic cells reside within heterozygous GATA-1 knockdown mice, bearing either an active wild-type GATA-1 allele or an active mutant GATA-1.05 allele. In the hematopoietic progenitors with the latter allele, low-level GATA-1 expression is sufficient to support survival and proliferation but not differentiation, leading to the accumulation of progenitors that are easily targeted by oncogenic stimuli. Since such leukemia has not been observed in GATA-1-null/X mutant mice, we conclude that the residual GATA-1 activity in the knockdown mice contributes to the development of the malignancy. This de novo model recapitulates the acute crisis found in preleukemic conditions in humans.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15572684      PMCID: PMC533998          DOI: 10.1128/MCB.24.24.10814-10825.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

Review 1.  Transcriptional regulation of erythropoiesis: an affair involving multiple partners.

Authors:  Alan B Cantor; Stuart H Orkin
Journal:  Oncogene       Date:  2002-05-13       Impact factor: 9.867

Review 2.  The management of neoplastic disorders of haematopoiesis in children with Down's syndrome.

Authors:  B Lange
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

Review 3.  Roles of hematopoietic transcription factors GATA-1 and GATA-2 in the development of red blood cell lineage.

Authors:  Kinuko Ohneda; Masayuki Yamamoto
Journal:  Acta Haematol       Date:  2002       Impact factor: 2.195

4.  GATA-1 and GATA-2 gene expression is related to the severity of dysplasia in myelodysplastic syndrome.

Authors:  S-A-W Fadilah; S-K Cheong; H Roslan; M Rozie-Hanisa; G-K Yen
Journal:  Leukemia       Date:  2002-08       Impact factor: 11.528

Review 5.  Transcriptional regulation of erythropoiesis. Fine tuning of combinatorial multi-domain elements.

Authors:  Chava Perry; Hermona Soreq
Journal:  Eur J Biochem       Date:  2002-08

6.  A GATA box in the GATA-1 gene hematopoietic enhancer is a critical element in the network of GATA factors and sites that regulate this gene.

Authors:  S Nishimura; S Takahashi; T Kuroha; N Suwabe; T Nagasawa; C Trainor; M Yamamoto
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

7.  In vivo requirements for GATA-1 functional domains during primitive and definitive erythropoiesis.

Authors:  R Shimizu; S Takahashi; K Ohneda; J D Engel; M Yamamoto
Journal:  EMBO J       Date:  2001-09-17       Impact factor: 11.598

8.  GATA factor transgenes under GATA-1 locus control rescue germline GATA-1 mutant deficiencies.

Authors:  S Takahashi; R Shimizu; N Suwabe; T Kuroha; K Yoh; J Ohta; S Nishimura; K C Lim; J D Engel; M Yamamoto
Journal:  Blood       Date:  2000-08-01       Impact factor: 22.113

9.  Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.

Authors:  Joshua Wechsler; Marianne Greene; Michael A McDevitt; John Anastasi; Judith E Karp; Michelle M Le Beau; John D Crispino
Journal:  Nat Genet       Date:  2002-08-12       Impact factor: 38.330

10.  Constitutive expression of GATA-1 interferes with the cell-cycle regulation.

Authors:  A Dubart; P H Roméo; W Vainchenker; D Dumenil
Journal:  Blood       Date:  1996-05-01       Impact factor: 22.113

View more
  26 in total

1.  The hypomorphic Gata1low mutation alters the proliferation/differentiation potential of the common megakaryocytic-erythroid progenitor.

Authors:  Barbara Ghinassi; Massimo Sanchez; Fabrizio Martelli; Giovanni Amabile; Alessandro Maria Vannucchi; Giovanni Migliaccio; Stuart H Orkin; Anna Rita Migliaccio
Journal:  Blood       Date:  2006-10-12       Impact factor: 22.113

Review 2.  GATA1 insufficiencies in primary myelofibrosis and other hematopoietic disorders: consequences for therapy.

Authors:  Te Ling; John D Crispino; Maria Zingariello; Fabrizio Martelli; Anna Rita Migliaccio
Journal:  Expert Rev Hematol       Date:  2018-02-19       Impact factor: 2.929

Review 3.  Evolution of myeloid leukemia in children with Down syndrome.

Authors:  Satoshi Saida
Journal:  Int J Hematol       Date:  2016-02-24       Impact factor: 2.490

4.  Transcriptional regulation by GATA1 and GATA2 during erythropoiesis.

Authors:  Mikiko Suzuki; Ritsuko Shimizu; Masayuki Yamamoto
Journal:  Int J Hematol       Date:  2011-02-01       Impact factor: 2.490

5.  Differential sensitivities of transcription factor target genes underlie cell type-specific gene expression profiles.

Authors:  Kirby D Johnson; Shin-Il Kim; Emery H Bresnick
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-16       Impact factor: 11.205

6.  LSD1 defines erythroleukemia metabolism by controlling the lineage-specific transcription factors GATA1 and C/EBPα.

Authors:  Kensaku Kohrogi; Shinjiro Hino; Akihisa Sakamoto; Kotaro Anan; Ryuta Takase; Hirotaka Araki; Yuko Hino; Kazutaka Araki; Tetsuya Sato; Kimitoshi Nakamura; Mitsuyoshi Nakao
Journal:  Blood Adv       Date:  2021-05-11

7.  Early block to erythromegakaryocytic development conferred by loss of transcription factor GATA-1.

Authors:  David L Stachura; Stella T Chou; Mitchell J Weiss
Journal:  Blood       Date:  2005-09-06       Impact factor: 22.113

8.  Phosphatidylinositol 3-kinase/Akt induced by erythropoietin renders the erythroid differentiation factor GATA-1 competent for TIMP-1 gene transactivation.

Authors:  Zahra Kadri; Leila Maouche-Chretien; Heather M Rooke; Stuart H Orkin; Paul-Henri Romeo; Patrick Mayeux; Philippe Leboulch; Stany Chretien
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

Review 9.  Concise review: preleukemic stem cells: molecular biology and clinical implications of the precursors to leukemia stem cells.

Authors:  Ashley Pandolfi; Laura Barreyro; Ulrich Steidl
Journal:  Stem Cells Transl Med       Date:  2013-01-24       Impact factor: 6.940

10.  Loss of the Gata1 gene IE exon leads to variant transcript expression and the production of a GATA1 protein lacking the N-terminal domain.

Authors:  Eri Kobayashi; Ritsuko Shimizu; Yuko Kikuchi; Satoru Takahashi; Masayuki Yamamoto
Journal:  J Biol Chem       Date:  2009-10-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.